The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

Severe Obesity Is On The Rise In The Us Obesity is high and holding steady in the U.S. About 4 in 10 Americans have obesity ...

Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Sanders found unlikely common ground with pro-Trump Elon Musk, citing the tech mogul as “right” on “solving obesity” in a ...

BioAge Labs, a biopharmaceutical startup focused on obesity drugs, is looking to raise nearly $200 million in its recently ...

The “SOOO Snatched” costume comes at a base price of $39.95, and the dress sure looks like your average Ozempic shot, just ...

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the me ...

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United ...

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.